Insights

Home Insights

As the project partner, BLA Regulatory congratulates ImmuneOnco on receiving US FDA approval of IMM2902 project IND

As the project partner, BLA Regulatory congratulates ImmuneOnco on receiving US FDA approval of IMM2902 project IND Gaithersburg, MD (25 August 2021) – BLA Regulatory, LLC, a full-service biopharma regulatory consultancy, announced that as the project partner, BLA Regulatory congratulates ImmuneOnco on receiving US FDA approval of IMM2902 project IND and initiating clinical investigation for […]